Advanced search
Publication Cover
Modern Rheumatology Volume 20, 2010 - Issue 2
Journal homepage
41
Views
3
CrossRef citations to date
0
Altmetric
Review Article

Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan

Shumpei YokotaDepartment of Pediatrics, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan e-mail: [email protected], [email protected]Correspondence[email protected]
,
Masaaki MoriDepartment of Pediatrics, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan e-mail: [email protected], [email protected]
,
Tomoyuki ImagawaDepartment of Pediatrics, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan e-mail: [email protected], [email protected]
,
Takuji MurataDepartment of Pediatrics, Osaka Medical College, 3-9 Fukuura, Kanazawa-ku 236-0004 Osaka, Japan e-mail: [email protected]
,
Minako TomiitaDepartment of Pediatrics, Graduate School of Medicine, Chiba University, 3-9 Fukuura, Kanazawa-ku 236-0004 Chiba, Japan e-mail: [email protected]
,
Yasuhiko ItohDepartment of Pediatrics, Nippon Medical School, 3-9 Fukuura, Kanazawa-ku 236-0004 Tokyo, Japan e-mail: [email protected]
,
Satoshi FujikawaInstitute of Rheumatology, Tokyo Women’s Medical University, 3-9 Fukuura, Kanazawa-ku 236-0004 Tokyo, Japan e-mail: [email protected]
&
Syuji TakeiSchool of Health Sciences, Faculty of Medicine, Kagoshima University, 3-9 Fukuura, Kanazawa-ku 236-0004 Kagoshima, Japan e-mail: [email protected]
 show all
Pages 107-113 | Received 24 Sep 2009, Accepted 16 Nov 2009, Published online: 02 Jan 2014

References

  • Yokota S, Mori M, Imagawa T, et al. Proposal for juvenile idi-opathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists. Mod Rheu-matol. 2007;17:353–63.
  • Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 1994;370:218–20.
  • Mohler KM, orrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol. 1993;151:1548–61.
  • Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor(p75)-Fc fusion protein. N Engl J Med. 1997;337: 141–7.
  • Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med. 1999;130:478–86.
  • Weinblatt ME, Kremer JM, Bankhust AD, Bulpitt KJ, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340:253–9.
  • Tanno M, Nakamura I, Ito K, et al. Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis. Mod Rheumatol. 2006;16:77–84.
  • Miyasaka N, Takeuchi T, Eguchi K. Guidelines for the proper use of etanercept in Japan. Mod Rheumatol. 2006;16(2):63–7.
  • Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342:763–9.
  • Horneff G, Schmeling H, Biedermann T, et al. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis. 2004;63:1638–44.
  • Cassidy JT, et al. Chronic arthritis, poly arthritis, oligoarthritis, systemic arthritis. In: Cassidy JT, Petty RE, Laxer RM, Linsley CB, editors. Textbook of pediatric rheumatology. 5th edn. Phil-adelphia: Elsevier Saunders; 2005. p. 206–303.
  • Harrington J, Kirk A, Newman S. Developmental issues in ado-lescence and the impact of rheumatic disease. In: Isenberg DA, Miller JJ, editors. Adolescent rheumatology. London: Martin Dunitz; 2000. p. 21–34.
  • Grom AA, Murray KJ, Luyrink L, et al. Pattern of expression of tumor necrosis factor a, tumor necrosis factor 13, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondyloarthropathy. Arthritis Rheum. 1996;39: 1703–10.
  • Eberhard BA, Laxer RM, Andersson U, Silverman ED. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol. 1994;96:260–6.
  • Fink CW. Proposal for the development of classification criteria for the idiopathic arthritis of childhood. J Rheumatol. 1995;22: 1566–9.
  • Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005;294:1671–84.
  • Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson. JC, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treat-ment trial. Arthritis Rheum. 2003;48:218–26.
  • Prevoo ML. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
  • Mori M, akei S, Imagawa T, Imanaka H, Maeno N, et al. Pharmacokinetics, efficacy and safety of short-term (12 weeks) etanercept for the methotrexate-refractory polyarticular juvenile idiopathic arthritis in Japan. Mod Rheumatol. 2005;15:397–404.
  • Elkayam O, Caspi D, Reiblattet T, et al. The effect of tumor necrosis factor blockade on the response to pneumococcal vac-cination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum. 2004;33:283–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.